Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team
- Former GlaxoSmithKline and Proximagen executive adds to Rewind´s drug discovery and development expertise Leuven, Belgium, November 29, 2022 --- Rewind Therapeutics, a company developing first-in-class treatments for…